Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A preliminary study of the effect of estrogen dose on growth in Turner's syndrome.

× No keyword cloud information.

23 in total

1. Association between ER-α polymorphisms and bone mineral density in patients with Turner syndrome subjected to estroprogestagen treatment--a pilot study.

Authors: Elżbieta Sowińska-Przepiera; Elżbieta Andrysiak-Mamos; Kornel Chełstowski; Grażyna Adler; Zbigniew Friebe; Anhelli Syrenicz
Journal: J Bone Miner Metab Date: 2011-01-27 Impact factor: 2.626

2. New aspects of oestrogen/gestagen-induced growth and endocrine changes in individuals with Turner syndrome.

Authors: H G Bohnet
Journal: Eur J Pediatr Date: 1986-09 Impact factor: 3.183

3. Skeletal size and bone mineral content in Turner's syndrome: relation to karyotype, estrogen treatment, physical fitness, and bone turnover.

Authors: R W Naeraa; K Brixen; R M Hansen; C Hasling; L Mosekilde; J H Andresen; P Charles; J Nielsen
Journal: Calcif Tissue Int Date: 1991-08 Impact factor: 4.333

4. Pharmacokinetics and pharmacodynamics of oral and transdermal 17β estradiol in girls with Turner syndrome.

Authors: Martha Taboada; Richard Santen; John Lima; Jobayer Hossain; Ravinder Singh; Karen Oerter Klein; Nelly Mauras
Journal: J Clin Endocrinol Metab Date: 2011-08-31 Impact factor: 5.958

5. Effects of low-dose estrogen replacement during childhood on pubertal development and gonadotropin concentrations in patients with Turner syndrome: results of a randomized, double-blind, placebo-controlled clinical trial.

Authors: Charmian A Quigley; Xiaohai Wan; Sipi Garg; Karen Kowal; Gordon B Cutler; Judith L Ross
Journal: J Clin Endocrinol Metab Date: 2014-04-24 Impact factor: 5.958

A preliminary study of the effect of estrogen dose on growth in Turner's syndrome.

1. Association between ER-α polymorphisms and bone mineral density in patients with Turner syndrome subjected to estroprogestagen treatment--a pilot study.

2. New aspects of oestrogen/gestagen-induced growth and endocrine changes in individuals with Turner syndrome.

3. Skeletal size and bone mineral content in Turner's syndrome: relation to karyotype, estrogen treatment, physical fitness, and bone turnover.

4. Pharmacokinetics and pharmacodynamics of oral and transdermal 17β estradiol in girls with Turner syndrome.

5. Effects of low-dose estrogen replacement during childhood on pubertal development and gonadotropin concentrations in patients with Turner syndrome: results of a randomized, double-blind, placebo-controlled clinical trial.

6. Identification of androgen receptors in normal human osteoblast-like cells.

7. Precocious puberty in girls: early diagnosis of a slowly progressing variant.

8. Growth hormone plus childhood low-dose estrogen in Turner's syndrome.

9. Prepubertal OVX increases IGF-I expression and bone accretion in C57BL/6J mice.

10. Recombinant human growth hormone in the treatment of Turner syndrome.